Shares gained 3% after hours.
Zacks Investment Research upgraded shares of Intuitive Surgical, Inc. Stephens Inc. AR now owns 255 shares of the medical equipment provider's stock worth $185,000 after buying an additional 111 shares in the last quarter. UBS Asset Management Americas Inc. boosted its stake in shares of Intuitive Surgical by 19.8% in the fourth quarter. Institutional investors and hedge funds own 91.16% of the company's stock.
TRADEMARK VIOLATION WARNING: "Intuitive Surgical (ISRG) Receives Daily News Impact Score of 0.45" was originally posted by Chaffey Breeze and is the sole property of of Chaffey Breeze. The company had a trading volume of 252,827 shares. Intuitive Surgical has a one year low of $610.71 and a one year high of $811.89. MO's profit will be $1.43 billion for 23.77 P/E if the $0.75 EPS becomes a reality.
The stock's 50 day moving average is 752.30 and its 200 day moving average is 692.46.
( ISRG ) announced a profit for its first quarter that gained ground compared to the same period past year. Barclays PLC reaffirmed a "buy" rating and issued a $800.00 target price on shares of Intuitive Surgical in a research report on Sunday, March 26th. Intuitive Surgical had a return on equity of 14.24% and a net margin of 27.21%.
Revenue for the quarter rose about 13 percent to $674 million, topping Wall Street forecasts of $666.5 million. Vident Investment Advisory LLC now owns 4,038 shares of the company's stock worth $2,561,000 after buying an additional 365 shares during the last quarter.
The number of da Vinci procedures rose by almost 18% compared to the year-ago quarter. Total expenses were 71.60 percent of quarterly revenues, up from 69.89 percent for the same period past year.
07/21/2016 - Intuitive Surgical, Inc. was downgraded to "under perform" by analysts at Northland Securities.
ISRG has been the subject of several research reports. The original version of this report can be read at https://baseballnewssource.com/markets/cim-llc-lowers-position-in-intuitive-surgical-inc-isrg/618365.html.
01/06/2017 - Intuitive Surgical, Inc. had its "neutral" rating reiterated by analysts at BTIG Research. Finally, Evercore ISI downgraded shares of Intuitive Surgical from a "buy" rating to a "hold" rating and set a $690.00 target price on the stock.in a research report on Wednesday, January 4th.
07/20/2016 - Intuitive Surgical, Inc. had its " rating reiterated by analysts at Citigroup. Over the past month the firm's stock is 1.27%, 14.40% for the last quarter, 6.21% for the past six-months and 21.11% for the a year ago. They now have a Dollars 785 price target on the stock. 222 shares were sold by Myriam Curet, worth $162,016. Also, SVP Mark J. Meltzer sold 8,750 shares of the firm's stock in a transaction that occurred on Tuesday, February 21st. Following the transaction, the senior vice president now directly owns 762 shares of the company's stock, valued at approximately $556,107.60. The transaction was disclosed in a document filed with the SEC, which is accessible through this link. They now have a Dollars 800 price target on the stock. The disclosure for this sale can be found here. Insiders have sold a total of 34,118 shares of company stock worth $25,064,571 in the last three months.
Nivalis Therapeutics Inc (NASDAQ:NVLS) could be in limelight on Wednesday as the company agreed to be merged with Alpine Immune Sciences through an all-stock agreement.
The company's 2017 guidance for surgical procedures with its da Vinci surgical system was "higher than we anticipated", said Raymond James analyst Lawrence Keusch. "Consistent with our mission, we strive to make surgery more effective, less invasive and easier on surgeons, patients and their families by actively engaging hospitals and surgical teams".